During the past decade, Zhejiang Cancer Hospital; Breast Surgery conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Zhejiang Cancer Hospital; Breast Surgery" are "HER2-positive Early Breast Cancer" (1 trials) and "Solid Tumor" (1 trials). Many other conditions were trialed in "Zhejiang Cancer Hospital; Breast Surgery" in a lesser frequency.

Most popular intervention types in "Zhejiang Cancer Hospital; Breast Surgery" are "Drug" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials), "Doxorubicin" (1 trials), "Hormone Therapy" (1 trials) and "Other Combination Anti-Cancer Therapies" (1 trials). Other intervention names were less common.

The vast majority of trials in "Zhejiang Cancer Hospital; Breast Surgery" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Zhejiang Cancer Hospital; Breast Surgery". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Zhejiang Cancer Hospital; Breast Surgery, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Zhejiang Cancer Hospital; Breast Surgery, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".